DEAL ANNOUNCEMENT / PRESS RELEASE
February 27, 2024
Read time: 3 min
McDermott Will & Emery represented Assured Healthcare Partners (AHP), a New York-based healthcare investment management firm, in its investment in Prolerity Clinical Research, LLC (Tandem), a clinical research site management network which operates 11 research sites across Louisiana, Florida, New Jersey and New York. Prolerity is focused on expanding into a leading site management network with a therapeutic breadth across complex and challenging phase I-III studies, including NASH/NAFLD, cardiology, CNS, gastroenterology, metabolic diseases and other therapeutic areas.
The McDermott team was led by Krist Werling, Travis Jackson and John Zukin and included Terry Brennan, Garrett Moores, Jeff Holdvogt, Jennifer Hill, Jennifer Mikulina, Ellie Atkins, Brian Mead, Benjamin Kryder, Kristi Mankowske, Kevin Hall, Andrew Granek, Jiayan Chen, Li Wang, Jacob Weissman, Caroline Reignley, Gregory Fosheim, Patrick Zanayed, Anisa Mohanty, Kyle Weber, Taylor Hood and Scott Weinstein.
McDermott’s private equity (PE) practice is among the top four most active PE law firms globally and in the US with more than 160 dedicated PE lawyers across 21 locations. We have ranked Pitchbook’s Top 5 Healthcare PE firm for six consecutive years and are Top 10 in PE Buyouts and other PE deals. We are also ranked as a Top 10 Global Mid-Market PE Firm by Bloomberg and #7 PE Law firm by The Deal. Learn more about our PE practice by visiting pe.mwe.com.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
